niacinamide has been researched along with Impaired Glucose Tolerance in 13 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Suddenly, he developed left cardiac failure, and he died 6 days later through a rapid clinical course that included circulatory failure, abnormal glucose tolerance, disseminated intravascular coagulation, and multiple organ failure." | 5.38 | [A case of fatal clinical course with reversible acute cardiac failure and glucose intolerance during sorafenib therapy for metastatic renal cell carcinoma]. ( Kimura, T; Miyagawa, T; Suetomi, T; Tsutsumi, M, 2012) |
| "Ecological evidence suggests that niacin (nicotinamide and nicotinic acid) fortification may be involved in the increased prevalence of obesity and type 2 diabetes, both of which are associated with insulin resistance and epigenetic changes." | 3.79 | Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats. ( Cao, JM; Cao, Y; Gong, XJ; Guo, J; Guo, M; Li, D; Lun, YZ; Luo, N; Sun, WP; Tian, YJ; Zhou, SS, 2013) |
| "In obesity and type 2 diabetes, Glut4 glucose transporter expression is decreased selectively in adipocytes." | 1.40 | Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. ( Alhonen, L; Asara, JM; Banks, AS; Bhanot, S; Cen, Y; Gong, F; Kahn, BB; Kong, D; Kraus, D; Monia, BP; Peroni, OD; Pirinen, E; Puigserver, P; Pulinilkunnil, TC; Rodgers, JT; Sauve, AA; Wang, YC; Yang, Q; Zhang, L, 2014) |
| "Suddenly, he developed left cardiac failure, and he died 6 days later through a rapid clinical course that included circulatory failure, abnormal glucose tolerance, disseminated intravascular coagulation, and multiple organ failure." | 1.38 | [A case of fatal clinical course with reversible acute cardiac failure and glucose intolerance during sorafenib therapy for metastatic renal cell carcinoma]. ( Kimura, T; Miyagawa, T; Suetomi, T; Tsutsumi, M, 2012) |
| " Subsequently, the effects of a 1-week chronic daily dosing of DPP-IV inhibitors and sulfonylureas were investigated." | 1.35 | Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice. ( Hayakawa, M; Matsuyama-Yokono, A; Nakano, R; Shibasaki, M; Shiraki, K; Someya, Y; Tahara, A, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Sambeat, A | 1 |
| Ratajczak, J | 1 |
| Joffraud, M | 1 |
| Sanchez-Garcia, JL | 1 |
| Giner, MP | 1 |
| Valsesia, A | 1 |
| Giroud-Gerbetant, J | 1 |
| Valera-Alberni, M | 1 |
| Cercillieux, A | 1 |
| Boutant, M | 1 |
| Kulkarni, SS | 1 |
| Moco, S | 1 |
| Canto, C | 1 |
| Shi, W | 1 |
| Hegeman, MA | 1 |
| Doncheva, A | 1 |
| Bekkenkamp-Grovenstein, M | 1 |
| de Boer, VCJ | 1 |
| Keijer, J | 1 |
| Cartwright, DM | 1 |
| Oakey, LA | 1 |
| Fletcher, RS | 1 |
| Doig, CL | 1 |
| Heising, S | 1 |
| Larner, DP | 1 |
| Nasteska, D | 1 |
| Berry, CE | 1 |
| Heaselgrave, SR | 1 |
| Ludwig, C | 1 |
| Hodson, DJ | 1 |
| Lavery, GG | 1 |
| Garten, A | 1 |
| Li, D | 1 |
| Tian, YJ | 1 |
| Guo, J | 1 |
| Sun, WP | 1 |
| Lun, YZ | 1 |
| Guo, M | 1 |
| Luo, N | 1 |
| Cao, Y | 1 |
| Cao, JM | 1 |
| Gong, XJ | 1 |
| Zhou, SS | 1 |
| Kraus, D | 1 |
| Yang, Q | 1 |
| Kong, D | 1 |
| Banks, AS | 1 |
| Zhang, L | 1 |
| Rodgers, JT | 1 |
| Pirinen, E | 1 |
| Pulinilkunnil, TC | 1 |
| Gong, F | 1 |
| Wang, YC | 1 |
| Cen, Y | 1 |
| Sauve, AA | 1 |
| Asara, JM | 1 |
| Peroni, OD | 1 |
| Monia, BP | 1 |
| Bhanot, S | 1 |
| Alhonen, L | 1 |
| Puigserver, P | 1 |
| Kahn, BB | 1 |
| Qi, Z | 1 |
| Xia, J | 1 |
| Xue, X | 1 |
| He, Q | 1 |
| Ji, L | 1 |
| Ding, S | 1 |
| Matsuyama-Yokono, A | 3 |
| Tahara, A | 3 |
| Nakano, R | 3 |
| Someya, Y | 3 |
| Hayakawa, M | 2 |
| Shibasaki, M | 3 |
| Shiraki, K | 1 |
| Shimizu, R | 1 |
| Sakazaki, F | 1 |
| Okuno, T | 1 |
| Nakamuro, K | 1 |
| Ueno, H | 1 |
| Kimura, T | 1 |
| Suetomi, T | 1 |
| Miyagawa, T | 1 |
| Tsutsumi, M | 1 |
| Novelli, M | 1 |
| D'Aleo, V | 1 |
| Lupi, R | 1 |
| Paolini, M | 1 |
| Soleti, A | 1 |
| Marchetti, P | 1 |
| Masiello, P | 1 |
| Sherr, J | 1 |
| Sosenko, J | 1 |
| Skyler, JS | 1 |
| Herold, KC | 1 |
1 review available for niacinamide and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Prevention of type 1 diabetes: the time has come.
Topics: Autoantibodies; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Epitopes; Glucose Intolerance; | 2008 |
12 other studies available for niacinamide and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage.
Topics: Animals; Blood Glucose; Diet, High-Fat; Disease Models, Animal; DNA Damage; Gene Knockout Techniques | 2019 |
High Dose of Dietary Nicotinamide Riboside Induces Glucose Intolerance and White Adipose Tissue Dysfunction in Mice Fed a Mildly Obesogenic Diet.
Topics: Adipose Tissue, White; Animals; Blood Glucose; Diet, High-Fat; Dose-Response Relationship, Drug; Ene | 2019 |
Nicotinamide riboside has minimal impact on energy metabolism in mouse models of mild obesity.
Topics: Animals; Cell Respiration; Diet, High-Fat; Disease Models, Animal; Drug Evaluation; Energy Metabolis | 2021 |
Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats.
Topics: Animals; Betaine; Choline; CpG Islands; Dietary Supplements; DNA; DNA Damage; DNA Methylation; Epige | 2013 |
Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.
Topics: Acetyltransferases; Adipocytes; Adipose Tissue; Adipose Tissue, White; Animals; Diabetes Mellitus, T | 2014 |
Long-term treatment with nicotinamide induces glucose intolerance and skeletal muscle lipotoxicity in normal chow-fed mice: compared to diet-induced obesity.
Topics: Animals; Antioxidants; Autophagy; Diet, High-Fat; Dietary Supplements; Gene Expression Regulation; G | 2016 |
Chronic inhibition of dipeptidyl peptidase-IV with ASP8497 improved the HbA(1c) level, glucose intolerance, and lipid parameter level in streptozotocin-nicotinamide-induced diabetic mice.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Dipeptidyl-Peptidase IV Inhibitors; | 2009 |
Effects of antidiabetic drugs on glucose tolerance in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon-Like Peptide 1; Glucose Intoleranc | 2008 |
Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Pepti | 2009 |
Difference in glucose intolerance between C57BL/6J and ICR strain mice with streptozotocin/nicotinamide-induced diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucose Intolerance | 2012 |
[A case of fatal clinical course with reversible acute cardiac failure and glucose intolerance during sorafenib therapy for metastatic renal cell carcinoma].
Topics: Acute Disease; Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Glucose Intole | 2012 |
Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitu | 2007 |